0001445064-15-000090.txt : 20150514
0001445064-15-000090.hdr.sgml : 20150514
20150514173417
ACCESSION NUMBER: 0001445064-15-000090
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150513
FILED AS OF DATE: 20150514
DATE AS OF CHANGE: 20150514
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Mallinckrodt plc
CENTRAL INDEX KEY: 0001567892
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 981088325
FISCAL YEAR END: 0930
BUSINESS ADDRESS:
STREET 1: DAMASTOWN
STREET 2: MULHUDDART
CITY: DUBLIN
STATE: L2
ZIP: 15
BUSINESS PHONE: 353 1 8808180
MAIL ADDRESS:
STREET 1: DAMASTOWN
STREET 2: MULHUDDART
CITY: DUBLIN
STATE: L2
ZIP: 15
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BAILEY DON M
CENTRAL INDEX KEY: 0001223697
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35803
FILM NUMBER: 15864247
MAIL ADDRESS:
STREET 1: 1300 N. KELLOGG DRIVE
STREET 2: SUITE D
CITY: ANAHEIM
STATE: CA
ZIP: 92607
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2015-05-13
0001567892
Mallinckrodt plc
MNK
0001223697
BAILEY DON M
675 MCDONNELL BLVD.
HAZELWOOD
MO
63042
1
0
0
0
Ordinary Shares
2015-05-13
4
M
0
51417
26.95
A
191024
D
Ordinary Shares
2015-05-13
4
S
0
50017
122.43
D
141007
D
Ordinary Shares
2015-05-13
4
S
0
1400
123.18
D
139607
D
Stock Options (Right to Buy)
26.95
2015-05-13
4
M
0
51417
0
D
2022-02-15
Ordinary Shares
51417
0
D
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on November 26, 2014.
The price represents a weighted average. The shares were sold at prices ranging from $122.02 to $123.00, inclusive. Mr. Bailey will provide, upon request of the SEC staff, Mallinckrodt plc, or a shareholder of Mallinckrodt plc complete information regarding the number of shares sold at each price within the ranges set forth in footnotes (2) - (3) to this Form 4.
The price represents a weighted average. The shares were sold at prices ranging from $123.12 to $123.50, inclusive.
Represents options to purchase shares of Questcor Pharmaceuticals, Inc. that were converted into options to purchase ordinary shares of Mallinckrodt plc pursuant to the Agreement and Plan of Merger, dated as of April 5, 2014, by and among Mallinckrodt plc ("Mallinckrodt"), Questcor Pharmaceuticals, Inc. ("Questcor") and Quincy Merger Sub, Inc. All unvested options were accelerated on August 14, 2014 in connection with the acquisition of Questcor by Mallinckrodt.
/s/Kenneth L. Wagner, Attorney-in-Fact
2015-05-14